Company Announces Update to Phase 3 XPORT-EC-042 Trial of Selinexor as Maintenance Therapy in Advanced or Recurrent TP53 Wild-Type Endometrial ...
Focuses on high-potential small-cap firms, boasting robust finances, attracting investors desiring growth and quality. Filters stocks below INR 7,500 Cr market cap, 5%+ EPS growth, and 15%+ RoE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback